Results on SARS-CoV-2-seroprevalence in the general population - Update September 2022
Date: 07/09/2022
Open Data
The data of our Study is available as Open Data, including information on the design and results of the studies as well as metadata and dataset documentation:
Results
Selected results on seroprevalence in the general population from studies conducted in Germany are regularly made available here.
Seroepidemiological SARS-CoV-2-studies in Germany by study location and time
SARS-CoV-2-seroprevalence in all participants over time, independent of vaccination status (studies from Germany)
Proportion of SARS-CoV-2-sero-positives in unvaccinated participants over time (studies from Germany)
Under-reporting factor showing how many times more infections have occurred compared to the hitherto known number of (reported) cases (studies from Germany)
Acknowledgement
We thank the SeroTracker team from the University of Calgary for helpful discussions and input to the operationalization of the study data scheme, as well as for programming elements for our static and interactive graphics.